A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The study is being performed to assess the safety, tolerability, and pharmacokinetic (PK) and
pharmacodynamic (PD) properties of multiple oral doses of DBPR108 in healthy male subjects.